Combined hormonal contraceptives are used to prevent pregnancies. They are also used in the treatment of acne vulgaris, endometriosis, polycystic ovarian syndrome, and irregular menstrual flow by blocking ovulation. These products are widely used by women of aged between 15 and 49 years.
The global Combined Hormonal Contraceptives market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Combined Hormonal Contraceptives volume and value at global level, regional level and company level. From a global perspective, this report represents overall Combined Hormonal Contraceptives market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Teva Pharmaceutical Industries
Johnson & Johnson
Segment by Regions
Segment by Type
Above 44 years
Combined Oral Contraceptive Pills
Combined Injectable Birth Control
Combined Emergency Contraceptive Pills
Combined Vaginal Rings
Combined Transdermal Patches
Segment by Application